| 标题 |
Mesutoclax (ICP-248) monotherapy or combined with orelabrutinib demonstrates encouraging activity and safety in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) poster |
| 网址 | |
| DOI |
10.1182/blood-2025-5677
doi
|
| 其它 | 我要poster哈 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)